Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Purchased by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. grew its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report) by 90.7% in the third quarter, Holdings Channel.com reports. The fund owned 22,582 shares of the company’s stock after purchasing an additional 10,740 shares during the period. Harbor Capital Advisors Inc.’s holdings in Acadia Healthcare were worth $1,432,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Congress Asset Management Co. increased its holdings in Acadia Healthcare by 16.8% during the 3rd quarter. Congress Asset Management Co. now owns 118,941 shares of the company’s stock valued at $7,542,000 after acquiring an additional 17,127 shares in the last quarter. State of Alaska Department of Revenue grew its holdings in Acadia Healthcare by 7.3% during the 3rd quarter. State of Alaska Department of Revenue now owns 10,735 shares of the company’s stock valued at $680,000 after buying an additional 730 shares during the last quarter. DekaBank Deutsche Girozentrale purchased a new position in Acadia Healthcare during the third quarter worth $86,000. Raymond James & Associates boosted its stake in shares of Acadia Healthcare by 24.8% during the third quarter. Raymond James & Associates now owns 124,202 shares of the company’s stock valued at $7,876,000 after acquiring an additional 24,709 shares during the last quarter. Finally, Inspire Investing LLC lifted its holdings in Acadia Healthcare by 27.2% in the 3rd quarter. Inspire Investing LLC now owns 6,647 shares of the company’s stock valued at $421,000 after purchasing an additional 1,421 shares in the last quarter.

Analysts Set New Price Targets

A number of brokerages have recently commented on ACHC. Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a report on Friday, September 20th. Barclays lowered their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday, September 30th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, October 1st. KeyCorp initiated coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $86.67.

View Our Latest Analysis on ACHC

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $42.51 on Wednesday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $3.95 billion, a P/E ratio of 13.94, a PEG ratio of 1.33 and a beta of 1.33. The firm has a fifty day moving average of $65.00 and a 200-day moving average of $67.55. Acadia Healthcare Company, Inc. has a 52-week low of $41.42 and a 52-week high of $87.77.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.91 EPS. As a group, analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Company Profile

(Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Read More

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.